Delivery Order SPE2DB22D2006-SPE2DB25FW1EC

Award Date 5/27/25
Potential Completion Date 5/28/25
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,540.06 firm fixed-price delivery order is for the supply of 4,567,925,570 units of the drug NAYZILAM 5 MG NASAL SPRAYS. The contract has an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,510.07, is for the delivery of NAYZILAM 5 MG NASAL SPRAYS and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,047.25, is for the delivery of NAYZILAM 5 MG NASAL SPRAYS. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,344.52, is for the delivery of NAYZILAM 5 MG nasal sprays. It is a firm fixed-price delivery order contract with an ultimate completion date of October 22, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,410.34 firm fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,827.83 firm fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS, with a completion date of April 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,724.31, is for the delivery of NAYZILAM 5 MG NASAL SPRAYS. This is a firm fixed-price delivery order contract with a period of performance through March 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,314.12 firm-fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS, a medication used to treat seizures. The contract has an ultimate completion date of August 13, 2024 and is not set aside for any specific business categories. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,391.00, is for the delivery of NAYZILAM 5 MG NASAL SPRAYS. The contract is a firm fixed-price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided about any subcontractors. This contract is...
This federal contract award is a delivery order valued at $2,168.72 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of NAYZILAM 5 MG NASAL SPRAYS, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of March 7, 2025 and is a firm fixed-price type. AmerisourceBergen holds a significant Indefinite Delivery...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FW1EC
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a $3,156.81 firm fixed-price delivery order for the supply of NAYZILAM 5 MG NASAL SPRAYS. The contract has an ultimate completion date of May 28, 2025. Amerisourcebergen Drug Corp also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle extending through December 2026. This IDC allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract award is not set aside for any specific business category.

Generated 8/31/25, 12:43 AM